(Q34120057)

English

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Yves P Auberson

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hans Allgeier

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Serge Bischoff

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kurt Lingenhoehl

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Robert Moretti

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Markus Schmutz

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1099-1102

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5-Aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900074-4

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Aminomethylquinoxaline-2,3-diones. Part II: N-aryl derivatives as novel NMDA/glycine and AMPA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900074-4

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900074-4

7 January 2021

based on heuristic

inferred from DOI database lookup

N-phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: in vivo active AMPA and NMDA(glycine) antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900074-4

7 January 2021

based on heuristic

inferred from DOI database lookup

3HCGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900074-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900074-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Binding of [3H]AMPA, a Structural Analogue of Glutamic Acid, to Rat Brain Membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900074-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(02)00074-4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34120057&oldid=1766426680"